Italian designer specified LVMH, L’Oréal or EssilorLuxottica as preferred buyers; foundation to retain 30% voting rights if public listing proceeds
Two-week IT shutdown has halted UK production, disrupted parts supply and prompted warnings that smaller suppliers may collapse unless ministers act
Planned project that would have created about 1,000 jobs is on hold amid industry withdrawals and warnings that Britain is becoming less attractive to drug companies
Stocks slipped as a report that officials will cite unverified VAERS reports in a presentation ahead of a CDC advisory meeting raised investor concern over policy and coverage implications
The drugmaker suspended plans for a 1,000‑job research hub as pharmaceutical investment shifts toward the United States
Keith Rabois, returning to the iBuyer amid activist pressure, vows deep staff reductions and a return to in‑person work after leadership change and volatile stock moves
Rabois, returning as chairman after an activist campaign, called the company 'broken' and said Opendoor needs fewer than 200 employees; the move follows management changes and a volatile stock rebound
Company says Cambridge expansion is 'paused' as other major pharma firms shift investment to the US amid concerns over UK support
Former San Francisco Giants outfielder puts 7,356-square-foot midcentury home on market as broadcasting career draws him back to the Bay Area